Kavli Affiliate: Charles M. Rice
| Authors: Mariana N Batista, Juliano Bordignon, Ana Luiza P Mosimann, Tesia Bobrowski, Hsuan-An Chen, Gabriel Tobin-Xet, Erika A Barrall, Nataliya Prokhnevska, Abishek B Vaidya, Tyler Lewy, Kenneth H Dinnon III, Leon L Seifert, Briana Zeck, Corrine Quirk, Yu-Jui Ho, Aveline Filiol, Raphael Wolfisberg, Caroline Jiang, Bruno Cogliati, Luis Chiriboga, Neil Theise, Margaret R MacDonald, Alice Kamphorst, Troels Kasper H Scheel, Timothy P Sheahan, Eva Billerbeck, Scott Lowe, Brad R Rosenberg and Charles M Rice
| Summary:
Hepatocellular carcinoma (HCC) is the third deadliest cancer worldwide. Over 75% of HCC cases are associated with chronic viral infections. Mechanistic studies and preclinical therapeutic development for virus-associated HCC have been limited by a paucity of small animal models of chronic hepatotropic virus infection that faithfully recapitulate human disease. Here we demonstrate the induction of chronic hepatitis, progressive liver fibrosis, and HCC in immunocompetent laboratory mice upon chronic viral infection with Norway rat hepacivirus (NrHV) – a virus closely related to hepatitis C virus (HCV). NrHV-elicited tumors resemble HCV-associated tumors and liver transcriptome analyses reveal numerous similarities between chronic NrHV and HCV. These findings establish an experimentally tractable, physiologically relevant, and immunocompetent mouse model of virus-elicited progressive liver fibrosis and oncogenesis.